Journal of Aging and Geriatric Psychiatry

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Editorial - Journal of Aging and Geriatric Psychiatry (2025) Volume 9, Issue 2

Advances in cognitive decline research and management

Dr. Priya Sharma*

Department of Psychiatry, AIIMS

*Corresponding Author:
Dr. Priya Sharma
Department of Psychiatry
AIIMS.
E-mail: priya.srma@aiims.edu

Received : 05-Jun-2025, Manuscript No. AAAGP-25-195; Editor assigned : 09-Jun-2025, PreQC No. AAAGP-25-195(PQ); Reviewed : 27-Jun-2025, QC No AAAGP-25-195; Revised : 08-Jul-2025, Manuscript No. AAAGP-25-195(R); Published : 17-Jul-2025 , DOI : 10.35841/aaagp-9.2.195

Citation: Sharma DP. Advances in cognitive decline research and managemen. J Age Geriat Psych. 2025;09(02):195.

Visit for more related articles at Journal of Aging and Geriatric Psychiatry

Introduction

This review explores the critical role of neuroinflammation, particularly the activation of microglia and astrocytes, in the progression of Alzheimer's Disease. It discusses various inflammatory pathways and highlights potential therapeutic targets aimed at modulating the immune response in the brain to slow or prevent neurodegeneration. Understanding these complex immunological processes, including the activation of microglia and astrocytes, is crucial for developing novel interventions against neurodegeneration, aiming to modulate the immune response within the brain effectively [1].

This paper offers an updated perspective on cognitive decline in Parkinson's Disease (PD), examining the complex changes that occur beyond motor symptoms. It covers the current diagnostic challenges, the underlying neuropathological mechanisms, and emerging pharmacological and non-pharmacological interventions aimed at preserving cognitive function in PD patients. Addressing these complex cognitive changes beyond motor symptoms is paramount for improving patient quality of life and informing future treatment strategies, encompassing both pharmacological and non-pharmacological approaches [2].

This article discusses the current understanding and future prospects of vascular cognitive impairment (VCI). It clarifies the diverse pathological mechanisms, including small vessel disease and stroke, that contribute to VCI. The authors emphasize the need for improved diagnostic criteria and targeted interventions given its increasing prevalence and overlap with other dementias. The multifaceted nature of VCI, driven by diverse pathological mechanisms like small vessel disease and stroke, demands a refined diagnostic approach to distinguish it from other forms of dementia and implement effective therapeutic measures given its increasing prevalence [3].

This comprehensive review outlines the current understanding of Mild Cognitive Impairment (MCI), covering its diagnostic criteria, diverse etiologies, and various management strategies. It highlights the importance of early detection and interventions to potentially delay or prevent the progression of MCI to more severe forms of dementia. Early detection and proactive management of MCI, considering its diverse etiologies, are crucial for potentially altering the disease trajectory and improving long-term outcomes for individuals, possibly preventing progression to more severe forms of dementia [4].

This article provides an update on Frontotemporal Dementia (FTD), detailing advances in understanding its complex pathogenesis, refining diagnostic approaches for its various clinical syndromes, and exploring novel treatment strategies. It emphasizes the genetic and molecular heterogeneity of FTD, which impacts therapeutic development. The distinct genetic and molecular underpinnings of FTD present unique challenges and opportunities for personalized therapeutic development, especially as advances refine diagnostic approaches for its various clinical syndromes [5].

This systematic review and meta-analysis evaluates the effectiveness of cognitive rehabilitation for individuals living with dementia. The findings suggest that certain cognitive rehabilitation interventions can lead to modest, yet significant, improvements in specific cognitive domains and daily functioning, highlighting its potential as a supportive therapy. These findings from systematic reviews and meta-analyses underscore the importance of integrating cognitive rehabilitation into comprehensive care plans for dementia patients, recognizing its potential as a supportive therapy [6].

This article details novel biomarkers essential for the early detection and precise differential diagnosis of Alzheimer's Disease and other neurodegenerative dementias. It reviews advancements in fluid and imaging biomarkers, discussing their role in improving diagnostic accuracy, monitoring disease progression, and facilitating clinical trial design. The continuous evolution of biomarker research, including fluid and imaging advancements, promises more accurate and timely diagnoses, which are critical for effective disease management, monitoring progression, and streamlining drug development efforts [7].

This review provides an update on the complex bidirectional relationship between sleep and cognitive decline. It highlights how sleep disturbances can both be a symptom and a risk factor for cognitive impairment and neurodegenerative diseases, emphasizing the importance of sleep health in maintaining cognitive function. Prioritizing healthy sleep patterns represents a significant non-pharmacological strategy to preserve cognitive function across the lifespan, acknowledging that sleep disturbances can act as both a symptom and a risk factor [8].

This article offers a practical guide to the diagnosis and management of Lewy Body Dementia (LBD). It details the clinical features, including cognitive fluctuations, visual hallucinations, and parkinsonism, crucial for early and accurate diagnosis, and outlines comprehensive strategies for managing both motor and non-motor symptoms. Comprehensive management of LBD requires an integrated approach that effectively addresses both motor and non-motor symptoms, necessitating a practical understanding of its distinct clinical features for early and accurate diagnosis [9].

This systematic review examines recent evidence regarding the influence of various dietary patterns on cognitive decline. It highlights the protective effects of diets like the Mediterranean and DASH diets, suggesting that nutritional interventions are a significant modifiable factor in maintaining cognitive health and potentially preventing dementia. Incorporating beneficial dietary patterns, such as the Mediterranean and DASH diets, offers a promising and accessible strategy for mitigating the risk and progression of cognitive decline, highlighting nutrition as a significant modifiable factor [10].

 

Conclusion

Recent research highlights the critical role of neuroinflammation in Alzheimer's Disease, focusing on microglia and astrocytes as therapeutic targets to slow neurodegeneration. Simultaneously, updated perspectives on cognitive decline in Parkinson's Disease emphasize diagnostic challenges, neuropathological mechanisms, and emerging interventions aimed at preserving cognitive function. Discussions also clarify the diverse pathological mechanisms contributing to vascular cognitive impairment (VCI), advocating for improved diagnostic criteria and targeted interventions. A comprehensive understanding of Mild Cognitive Impairment (MCI) covers its diagnostic criteria, varied etiologies, and management strategies, underscoring the importance of early detection to prevent progression to more severe dementias. Advances in Frontotemporal Dementia (FTD) reveal complex pathogenesis, refined diagnostic approaches, and novel treatment strategies, noting its significant genetic and molecular heterogeneity. In terms of interventions, systematic reviews show cognitive rehabilitation offers modest but significant improvements in cognitive domains and daily functioning for individuals with dementia. The field also sees progress in novel biomarkers for early and differential diagnosis of Alzheimer's and other neurodegenerative dementias, leveraging fluid and imaging techniques to enhance accuracy and clinical trial design. The bidirectional relationship between sleep and cognitive decline is explored, stressing sleep health for maintaining cognitive function. Practical guides detail the diagnosis and management of Lewy Body Dementia (LBD), outlining strategies for motor and non-motor symptoms. Finally, evidence suggests certain dietary patterns, like Mediterranean and DASH diets, act as modifiable factors in preventing cognitive decline.

References

    1. Giovanni T, Laura L, Caterina S. Neuroinflammation in Alzheimer’s Disease: Targeting Microglia and Astrocytes. Cells. 2024;13(8):686.

Indexed at, Google Scholar, Crossref

    1. Valentina L, Federica R, Kian FC. Cognitive Decline in Parkinson's Disease: Current Perspectives and Future Directions. J Parkinsons Dis. 2023;13(6):849-866.

Indexed at, Google Scholar, Crossref

    1. Anna MN, Nikolaos S, Andrew JDW. Vascular cognitive impairment: current status and future prospects. Brain. 2021;144(1):1-17.

Indexed at, Google Scholar, Crossref

    1. Sangjoon K, Hyemin J, Jeongwon L. Current Understanding of Mild Cognitive Impairment: Diagnostic Criteria, Etiology, and Management Strategies. J Alzheimers Dis. 2022;87(1):1-18.

Indexed at, Google Scholar, Crossref

    1. Rik GvdE, Lot AvdM, Yolande ALP. Frontotemporal dementia: advances in understanding pathogenesis, diagnosis, and treatment. Lancet Neurol. 2020;19(8):669-683.

Indexed at, Google Scholar, Crossref

    1. Katie P, Fiona E, Rachael D. Cognitive Rehabilitation for People with Dementia: A Systematic Review and Meta-Analysis. Gerontologist. 2023;63(4):708-724.

Indexed at, Google Scholar, Crossref

    1. Charlotte EJKT, Rik V, Kaj B. Novel Biomarkers for Early Detection and Differential Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementias. Annu Rev Med. 2021;72:427-446.

Indexed at, Google Scholar, Crossref

    1. Laura AB, Alice JSLB, John WB. Sleep and Cognitive Decline: An Update on the Bidirectional Relationship. Curr Neurol Neurosci Rep. 2021;21(3):13.

Indexed at, Google Scholar, Crossref

    1. Douglas EG, Ian GM, Dag A. Lewy body dementia: A practical approach to diagnosis and management. Pract Neurol. 2022;22(4):268-279.

Indexed at, Google Scholar, Crossref

    1. Francesca R, Giuseppe DR, Michele S. Dietary patterns and cognitive decline: A systematic review of recent evidence. Nutr Neurosci. 2023;26(1):15-30.

Indexed at, Google Scholar, Crossref

Get the App